Bon Secours Buys Surgery Partners for $5.7B: Q&A

TL;DR: HealthSpan Partners, an affiliate of Bon Secours Mercy Health, agreed on October 26, 2026 to buy Surgery Partners in an all-cash deal valued at about $5.7 billion, according to Surgery Partners' press release. Public shareholders get $23.50 a share. Bain Capital will roll over its shares into the buyer. Closing is expected in the first quarter of 2027.

If your fund owns surgery centers or physician groups, this deal is a rare look at who buys them. The buyer is a hospital system's affiliate, not another buyout firm, and that changes the exit math.

What exactly was announced?

According to Surgery Partners' own press release, HealthSpan Partners will acquire Surgery Partners (NASDAQ: SGRY) at an enterprise value of roughly $5.7 billion. Shareholders other than Bain Capital affiliates receive $23.50 in cash per share. The company says the deal adds more than 200 locations across 30 states and about 5,000 affiliated physicians.

The buyer is a nonprofit system's affiliate, not a financial sponsor. Healthcare Dive reports that HealthSpan Partners will take the outpatient surgery provider private.

Eric Evans, Surgery Partners' CEO, said in the announcement that he appreciated that HealthSpan Partners "recognizes the significant value that our physician partners and our colleagues have created for the communities we serve," per Chief Healthcare Executive.

What do the numbers look like?

The price is a premium to where the stock traded, but below an earlier offer. Axios reports the $23.50 price is a 49.2% premium over Friday's close. It also reports the deal comes after Surgery Partners rejected a richer take-private bid from Bain. Becker's ASC puts that rejected bid at $25.75 per share.

Item	Figure	Source
Enterprise value	About $5.7 billion	Surgery Partners press release
Cash per public share	$23.50	Surgery Partners press release
Premium to Friday close	49.2%	Axios
Bain Capital's prior offer	$25.75 per share	Becker's ASC
Bain Capital stake	About 39%	Healthcare Dive
Expected close	Q1 2027	Surgery Partners press release

Axios puts Bain's stake at 38.5%, while Healthcare Dive reports 39%. The two sources differ by half a point, and the table uses Healthcare Dive's figure.

Why is Bain staying in?

Bain isn't cashing out. Healthcare Dive reports that Bain will roll over its shares in exchange for equity interests in HealthSpan Partners, and Axios says the stake it holds is expected to be maintained.

A rollover tells you something a headline price can't. The sponsor that knows the business best chose to keep exposure, even though the price sits below its own earlier bid. Ask what it knows before you read too much into the price.

Why does a hospital system want surgery centers?

Outpatient surgery is where systems are trying to grow. Axios says the deal would greatly expand the nonprofit's outpatient services and help patients avoid hospitals. Healthcare Dive adds that joint replacements and spinal fusions are especially lucrative, with Surgery Partners reporting a 22% increase in joint replacements alone last year.

Ascension has made a similar move. Becker's notes that its $3.9 billion purchase of Amsurg took it from 58 ASCs to more than 300.

The market is still fragmented. ASC News reports that even USPI and UnitedHealth Group's SCA Health hold just 5% and 8% of the market, and Surgery Partners controls about 2%.

What does it mean for private-markets investors?

Exits are where this matters for you. Axios says the deal "could open new exit options for sponsors holding scaled doctor group assets that heretofore have had no real strategic buyers." That's Axios's read, not a confirmed trend.

The downside is just as plain. If only a handful of hospital systems can write checks this size, a sponsor with a scaled doctor group may face one or two bidders, and a thin field tends to set the price. That is an inference, not a reported fact, but it is the risk to price in.

If you hold, or are being pitched, a fund with healthcare services exposure, ask the sponsor who the realistic buyers are at exit. A nonprofit system with a large balance sheet is a different counterparty from another buyout fund. For how sponsor-to-sponsor exits work by comparison, see our look at Harvest Partners' purchase of Integra Testing Services. Two other exit routes are covered in our pieces on PE secondary stakes and KKR's Flow Control deal and the Peterson Partners continuation vehicle for Kelso Industries.

The deal isn't done. It still needs Surgery Partners shareholder approval and regulatory approvals, per the company release.

Common mistakes when reading a deal like this

Treating the premium as the whole story is the easy one. A 49.2% premium over a single Friday close says little about whether $23.50 is fair against the $25.75 that Bain offered earlier.

Reading enterprise value as the equity check is another. The $5.7 billion figure includes debt, per Becker's, so it overstates what shareholders receive.

And a signed agreement isn't a closed deal. Shareholder and regulatory approval are still ahead, and either can change the timeline.

FAQ

Who is buying Surgery Partners?

HealthSpan Partners, a contractual affiliate and supporting organization of Bon Secours Mercy Health, announced the agreement on October 26, 2026. Bain Capital, which owns about 39% per Healthcare Dive, will roll over its shares into HealthSpan Partners equity.

How much are shareholders getting?

Shareholders other than Bain Capital affiliates receive $23.50 in cash per share, per Surgery Partners' release. The enterprise value is about $5.7 billion, including debt.

When will the deal close?

The companies expect to close in the first quarter of 2027. That depends on Surgery Partners shareholder approval, regulatory approvals and other customary conditions.

What does Surgery Partners operate?

It is a short-stay surgical facility owner and operator with more than 200 locations in 30 states. They include ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.

What to do today

If you own a private fund with healthcare services holdings, ask the sponsor who the likely buyers are for the largest position, and what price the last exit actually cleared at. To get deal breakdowns like this one each week, sign up for the free AIN briefing.

Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.